Literature DB >> 18175353

Role of attentional resources on gait performance in Huntington's disease.

Arnaud Delval1, Pierre Krystkowiak, Marie Delliaux, Kathy Dujardin, Jean-Louis Blatt, Alain Destée, Philippe Derambure, Luc Defebvre.   

Abstract

Patients with Huntington's disease (HD) suffer from cognitive deficits with impaired executive functions, including limited attentional resources. We sought to use a dual-task paradigm to evaluate attentional demands and the ability of patients with HD to concentrate on two tasks simultaneously. We analyzed the interference effects of cognitive and motor tasks on walking in HD and the contribution of clinical symptoms to gait disturbances. Patients and controls were asked to perform either a motor task (carrying a tray with four glasses), a cognitive task (counting backwards), or no task at all while walking at their preferred speed. Kinematic spatial parameters, temporal parameters, and angular parameters related to gait were recorded in 15 patients and 15 controls by means of a videomotion analysis system. Gait instability was assessed using the stride-to-stride variability of the various gait parameters. For patients with HD, performing a concurrent cognitive task resulted in a lower gait speed (compared with free walking), with decreased cadence and stride length. However, this effect was not observed in controls. Performing a motor task did not change any kinematic gait parameters in either HD or control subjects. We found correlations between gait speed in the dual cognitive/walking task on one hand and the motor UHDRS score, cognitive status and executive function on the other. Patients with HD had greater difficulty walking while performing a concurrent cognitive task; the drain on attentional resources deteriorated walking performance. 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2008        PMID: 18175353     DOI: 10.1002/mds.21896

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.

Authors:  Surekha Ramachandran; Sumathi Thangarajan
Journal:  Metab Brain Dis       Date:  2018-05-31       Impact factor: 3.584

2.  Effects of task difficulty during dual-task circle tracing in Huntington's disease.

Authors:  Eleftheria Vaportzis; Nellie Georgiou-Karistianis; Andrew Churchyard; Julie C Stout
Journal:  J Neurol       Date:  2014-11-05       Impact factor: 4.849

3.  Attentional mechanisms contributing to balance constraints during gait: the effects of balance impairments.

Authors:  Ka-Chun Siu; Li-Shan Chou; Ulrich Mayr; Paul van Donkelaar; Marjorie H Woollacott
Journal:  Brain Res       Date:  2008-11-12       Impact factor: 3.252

4.  The Effects of Dual-Task Cognitive Interference and Environmental Challenges on Balance in Huntington's Disease.

Authors:  Nicollette L Purcell; Jennifer G Goldman; Bichun Ouyang; Bryan Bernard; Joan A O'Keefe
Journal:  Mov Disord Clin Pract       Date:  2019-01-16

5.  Effect of tetrabenazine on motor function in patients with huntington disease.

Authors:  Joseph M Ferrara; Giovanni Mostile; Christine Hunter; Octavian R Adam; Joseph Jankovic
Journal:  Neurol Ther       Date:  2012-09-29

6.  Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.

Authors:  Emma Yhnell; Mariah J Lelos; Stephen B Dunnett; Simon P Brooks
Journal:  Exp Neurol       Date:  2016-05-07       Impact factor: 5.330

7.  A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.

Authors:  Emma Yhnell; Stephen B Dunnett; Simon P Brooks
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

8.  Walking-Related Dual-Task Interference in Early-to-Middle-Stage Huntington's Disease: An Auditory Event Related Potential Study.

Authors:  Marina de Tommaso; Katia Ricci; Anna Montemurno; Eleonora Vecchio; Sara Invitto
Journal:  Front Psychol       Date:  2017-07-31

9.  Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

Authors:  Melanie Alpaugh; Danny Galleguillos; Juan Forero; Luis Carlos Morales; Sebastian W Lackey; Preeti Kar; Alba Di Pardo; Andrew Holt; Bradley J Kerr; Kathryn G Todd; Glen B Baker; Karim Fouad; Simonetta Sipione
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137

10.  Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility study.

Authors:  Emma Yhnell; Hannah Furby; Rachel S Breen; Lucy C Brookes-Howell; Cheney J G Drew; Rebecca Playle; Gareth Watson; Claudia Metzler-Baddeley; Anne E Rosser; Monica E Busse
Journal:  Pilot Feasibility Stud       Date:  2018-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.